[1] Liao Q, Wan CM, Zhu Y,et al. Current status of research on infantile cholestatic liver disease in China: a visualization analysis. Zhongguo Dang Dai Er Ke Za Zhi,2017,19:529-533. [2] Moreira-Silva H, Maio I, Bandeira A, et al. Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms. Eur J Pediatr,2019,178:515-523. [3] Qin H, Zhang LL, Xiong XL, et al. Improves infantile cholestasis hepatopathy through inhibiting calcium-sensing receptor-mediated hepatocyte apoptosis. Front Pharmacol,2020,11:156. [4] 李静,熊励晶,杜丽娜,等.Citrin缺乏所致新生儿肝内胆汁淤积症预后分析.肝脏,2020,25:961-964. [5] Moyer V,Freese DK,Whitington PF,et al.Guideline for the evaluation of cholestatic jaundice in infants:recommendations of the north american society for pediatric gastroenterology,hepatology and nutrition. J Pediatr Gastroenterol Nutr,2004,39:115-128. [6] 李盼,郭静,孙梅.遗传代谢筛查对婴儿胆汁淤积性肝病诊治的意义.中国小儿急救医学,2019:353-357. [7] 董琛,黄志华.婴儿胆汁淤积性肝病的诊断及鉴别诊断.中华实用儿科临床杂志,2018,33:1441-1447. [8] Zhao RQ, Guan XQ, Luo ZG, et al. Clinical significance of histopathologic and ultrastructural pathologic examination in etiological diagnosis of infantile cholestatic diseases. Zhonghua Gan Zang Bing Za Zhi,2010,18:694-698. [9] Lee CS, Kimura A, Wu JF, et al. Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis. J Lipid Res,2017,58:607-614. [10] Li WW, Shan JJ, Lin LL, et al. Disturbance in Plasma Metabolic Profile in Different Types of Human Cytomegalovirus-Induced Liver Injury in Infants. Sci Rep,2017,7:15696. [11] 国志尊,邓志华.遗传性高胆红素血症及胆汁淤积的基因诊断.国际遗传学杂志,2019,42:419-425. [12] Gao ML, Zhong XM, Ma X,et al. Target gene sequence capture and next generation sequencing technology to diagnose four children with Alagille syndrome. Zhonghua Er Ke Za Zhi,2016,54:441-445. [13] 罗玲英,杨丽,范小刚,等.SLC25A13基因突变在Citrin缺陷新生儿肝内胆汁淤积症生化指标变化中的临床意义.临床和实验医学杂志,2019,18:2081-2084. |